Kattan MW - Search Results

1

Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.

Nguyen CT, Kattan MW. Nguyen CT, et al. Among authors: kattan mw. Cancer. 2009 Jul 1;115(13 Suppl):3039-45. doi: 10.1002/cncr.24355. Cancer. 2009. PMID: 19544545 Free article.

2

Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.

Shariat SF, Bergamaschi F, Adler HL, Nguyen C, Kattan MW, Wheeler TM, Slawin KM. Shariat SF, et al. Among authors: kattan mw. Urology. 2000 Sep 1;56(3):423-9. doi: 10.1016/s0090-4295(00)00648-8. Urology. 2000. PMID: 10962307

3

Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.

Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM. Slawin KM, et al. Among authors: kattan mw. Cancer Res. 2000 Dec 15;60(24):7142-8. Cancer Res. 2000. PMID: 11156423

4

Predicting outcomes in renal cell carcinoma.

Lane BR, Kattan MW. Lane BR, et al. Among authors: kattan mw. Curr Opin Urol. 2005 Sep;15(5):289-97. doi: 10.1097/01.mou.0000178336.94991.17. Curr Opin Urol. 2005. PMID: 16093851 Review.

5

Nomograms for prostate cancer.

Stephenson AJ, Kattan MW. Stephenson AJ, et al. Among authors: kattan mw. BJU Int. 2006 Jul;98(1):39-46. doi: 10.1111/j.1464-410X.2006.06173.x. BJU Int. 2006. PMID: 16831140 Review. No abstract available.

6

A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.

Sekeres MA, Fu AZ, Maciejewski JP, Golshayan AR, Kalaycio ME, Kattan MW. Sekeres MA, et al. Among authors: kattan mw. Cancer. 2007 Mar 15;109(6):1125-32. doi: 10.1002/cncr.22497. Cancer. 2007. PMID: 17265521 Free article.

7

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A. Stephenson AJ, et al. Among authors: kattan mw. J Clin Oncol. 2007 May 20;25(15):2035-41. doi: 10.1200/JCO.2006.08.9607. J Clin Oncol. 2007. PMID: 17513807 Free PMC article.

8

Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent.

Kattan MW, Cuzick J, Fisher G, Berney DM, Oliver T, Foster CS, Møller H, Reuter V, Fearn P, Eastham J, Scardino PT; Transatlantic Prostate Group. Kattan MW, et al. Cancer. 2008 Jan 1;112(1):69-74. doi: 10.1002/cncr.23106. Cancer. 2008. PMID: 18000803 Free PMC article.

9

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.

Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schröder FH, Klein EA. Dong F, et al. Among authors: kattan mw. J Urol. 2008 Jul;180(1):150-4; discussion 154. doi: 10.1016/j.juro.2008.03.053. Epub 2008 May 15. J Urol. 2008. PMID: 18485398

10

An updated catalog of prostate cancer predictive tools.

Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. Shariat SF, et al. Among authors: kattan mw. Cancer. 2008 Dec 1;113(11):3075-99. doi: 10.1002/cncr.23908. Cancer. 2008. PMID: 18823041 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

699 results

Search Page